NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update

Lee, Stephanie J. and Williams, Kirsten M. and Sarantopoulos, Stefanie and Kitko, Carrie L. and Cutler, Corey and Pidala, Joseph and Hill, Geoffrey R. and Defilipp, Zachariah and Greinix, Hildegard T. and Wolff, Daniel and Paczesny, Sophie and Cuvelier, Geoffrey D. E. and Schultz, Kirk R. and Pavletic, Steven Z. (2025) NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update. TRANSPLANTATION AND CELLULAR THERAPY, 31 (9). 6780-6.78E+018. ISSN 2666-6375, 2666-6367

Full text not available from this repository. (Request a copy)

Abstract

In 2020, the third NIH Consensus Development Project on Criteria for Chronic Graft-versus-Host Disease (GVHD) Clinical Trials was held with the goals of identifying gaps in understanding, prevention and treatment of chronic graft-versus-host disease (GVHD) and making actionable recommendations that would advance the field. An interim meeting was held in October 2024 to review progress on the 2020 recommendations. Each group was charged with reviewing their previous recommendations, assessing whether the field is on track to eventually achieve the goals, and considering whether recommendations should be modified in light of new data or insufficient progress. This manuscript summarizes the Working Groups' reports and helps define the research agenda for future studies in chronic GVHD. Overall, modest progress has been made on most initiatives. Some studies in progress will address key recommendations and results are eagerly anticipated. (c) 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Item Type: Article
Uncontrolled Keywords: BRONCHIOLITIS OBLITERANS SYNDROME; HEMATOPOIETIC-CELL TRANSPLANTATION; DEVELOPMENT PROJECT; CLINICAL-TRIALS; CHRONIC GVHD; T-CELLS; CRITERIA; PREVENTION; DIAGNOSIS; DEPLETION; Allogeneic; transplantation Chronic GvHD; TREATMENT; BIOMARKERS CONFERENCE
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 01 Apr 2026 05:47
Last Modified: 01 Apr 2026 05:47
URI: https://pred.uni-regensburg.de/id/eprint/67784

Actions (login required)

View Item View Item